ARROW QuickFlash Radial Artery Catherization (wire, guide, catheter), Part Numbers: a) REF AK-04220; b) REF ASK-04220-FMH1; c) REF ASK-04220-HHC; d) REF ASK-04220-KSP; e) REF ASK-04220-PSU; f) REF ASK-04220-UCL1; g) REF ASK-04500-AH; h) REF ASK-04500-HF-S; i) REF NA-04220-S1A; j) REF NA-04220-X1A; k) REF RA-04220; l) REF RA-04220-W
- Company
- Arrow International Inc.
- Recall Initiated
- February 12, 2024
- Posted
- March 21, 2024
- Recall Number
- Z-1267-2024
- Quantity
- 1,160,470 devices
- Firm Location
- Morrisville, NC
Reason for Recall
Teleflex is initiating this voluntary recall for the above-mentioned products due to reports received indicating a potentially defective component. The complaints received relate to resistance of the guidewire handle/chamber during use. The possible immediate health consequences of the component issue are arterial vasospasm and vessel injury arising from multiple arterial punctures with repeated attempts.
Distribution
Worldwide distribution: US (nationwide) and OUS (foreign) to countries of: AE, AR, AT, AU, BE, BH, BR, CA, CN, CO, CY, DE, EC, EE, ES, FR, GR, HK, HR, IT, KW, LB, LU, MX, MY, NL, NZ, PH, PL, QA, RU, SA, SE, SG, SI, TH, TW, and UK.
Lot / Code Info
a) REF AK-04220, UDI/DI 20801902190943, Lot Numbers: 13F22E0436, 13F22H0360, 33F23E0375, 33F23K0032, 33F23J0443, 33F23L0862; UDI/DI 30801902121616, Lot Numbers: 13F22L0105, 13F23A0651, 33F23C0100, 33F23F0347, 33F23E0501, 33F23G0141; b) REF ASK-04220-FMH1, UDI/DI 20801902111665, Lot Numbers: 33F23B0525, 33F23H0100; c) REF ASK-04220-HHC, UDI/DI 20801902190851, Lot Numbers: 33F23F0067, 33F23K0278, 33F23G0478, 33F23H0101; d) REF ASK-04220-KSP, UDI/DI 20801902156406, Lot Numbers: 33F23E0709, 33F23H0102, 33F23H0918, 33F23J0607; e) REF ASK-04220-PSU, UDI/DI 40801902121446, Lot Numbers: 33F23F0331, 33F23G0663; f) REF ASK-04220-UCL1, UDI/DI 20801902159124, Lot Numbers: 33F23F0801, 33F23C0726, 33F23H0320; g) REF ASK-04500-AH, UDI/DI 20801902114048, Lot Numbers: 33F23E0731, 33F23H0103, 33F23H0395; h) REF ASK-04500-HF-S, UDI/DI 40801902118002, Lot Numbers: 33F23F0202, 33F23H0104, 33F23H0396; i) REF NA-04220-S1A, UDI/DI 20801902139416, Lot Numbers: 33F23J0671; j) REF NA-04220-X1A, UDI/DI 20801902136606, Lot Numbers: 33F23F0704; k) REF RA-04220, UDI/DI 20801902180678, Lot Numbers: 14F23B0041; UDI/DI 30801902193309, Lot Numbers: 14F21L0189, 14F21L0190, 14F21L0250, 14F21L0251, 14F21L0252, 14F21L0253, 14F21M0130, 14F21M0131, 14F21M0205, 14F21M0206, 14F22A0044, 14F22A0123, 14F22A0124, 14F22A0143, 14F22A0144, 14F22B0163, 14F22B0164, 14F22B0175, 14F22C0017, 14F22C0018, 14F22C0019, 14F22C0020, 14F22C0021, 14F22C0022, 14F22C0216, 14F22C0284, 14F22C0346, 14F22C0347, 14F22D0023, 14F22D0024, 14F22D0110, 14F22D0217, 14F22D0291, 14S22D0218, 14F22E0016, 14F22E0173, 14F22E0215, 14F22F0003, 14F22F0062, 14F22F0208, 14F22F0209, 14F22F0210, 14F22F0212, 14F22F0335, 14F22F0336, 14F22G0297, 14F22G0298, 14F22G0325, 14F22G0326, 14F22H0078, 14F22H0079, 14F22H0250, 14F22J0078, 14F22J0079, 14F22J0080, 14F22J0081, 14F22J0082, 14F22J0083, 14F22J0257; UDI/DI 30801902210631, Lot Numbers: 14F22K0182, 14F22K0183, 14F22K0184, 14F22K0185, 14F22K0223, 14F22M0032, 14F22M0033, 14F22M0034, 14F22M0035, 14F22M0036, 14F22M0132, 14F23B0042, 14F23B0142, 14F23B0143, 14F23B0144, 14F23B0154, 14F23D0203, 14F23D0204, 14F23D0205, 14F23D0206, 14F23D0207, 14F23E0093, 14F23E0094, 14F23E0210, 14F23E0211, 14F23F0036, 14F23F0037, 14F23F0038, 14F23F0252, 14F23F0253, 14F23F0377, 14F23F0378, 14F23F0379, 14F23G0147, 14F23G0148, 14F23G0149, 14F23G0150, 14F23G0151, 14F23G0252, 14F23H0087, 14F23H0088, 14F23H0089, 14F23H0090, 14F23H0163, 14F23H0253, 14F23H0254, 14F23H0255, 14F23J0031, 14F23J0032, 14F23J0137, 14F23J0138, 14F23J0276, 14F23J0277; l) REF RA-04220-W, UDI/DI 30801902193316, Lot Numbers: 13F22E0142, 13F22H0417, 13F22J0586, 13F22M0442, 13F23C0015, 13F23J0017; UDI/DI 30801902202988, Lot Numbers: 13F22F0124, 13F23B0363, 13F23H0010, 13F23J0013, 13F23K0001
Root Cause
Process control
Action Taken
Teleflex/ARROW INTERNATIONAL issued an "URGENT MEDICAL DEVICE RECALL" notice to its consignees on 02/12/2024 via letter delivered via FedEx. The notice explained the issue, potential risk, and requested the following actions: Identify affected product in inventory, cease use, and quarantine pending return. If affected product is found, mark the applicable checkbox on the Acknowledgement Form and fax it to 1-855-419-8507, including Attn: Customer Service or using the e-mail address recalls@teleflex.com. A customer service representative will contact you with a Return Goods Authorization (RGA) Number and will provide instructions for the return of products to Teleflex Medical. If no product is inventory or on hand, mark the applicable checkbox on the Acknowledgement Form and return the form to Teleflex at the contact details provided. Distributors: Provide this field safety notice to all customers who have received impacted product. Each of your customers is then required to complete the Acknowledgement Form and return it to you. Immediately check your inventory for impacted product. Cease use and distribution of impacted product and immediately quarantine the affected product. You may then return all product in scope. Should you require further information or support concerning this issue, please contact Customer Service via email: recalls@teleflex.com, phone: 1-866-396-2111, or FAX: 1-855-419-8507 using the details provided below. Customer Service hours of operation are 8am 7pm EST.